![Anna Steeger](https://cdn.zonebourse.com/static/resize/768/576//static/images/insiders/unknown.png)
Anna Steeger
Amministratore Delegato presso PentixaPharm GmbH
Posizioni attive di Anna Steeger
Società | Posizione | Inizio | Fine |
---|---|---|---|
1717 Life Sciences Ventures GmbH | Investitore di Private Equity | 01/01/2017 | - |
Polyventures GmbH | Amministratore Delegato | - | - |
PentixaPharm GmbH
![]() PentixaPharm GmbH Miscellaneous Commercial ServicesCommercial Services Pentixapharm GmbH engages in the development, production, marketing, and distribution of medicines and radiopharmaceutical products, which act on the CXCR4 receptor. The company was founded on May 14, 2019 and is headquartered in Wuerzburg, Germany. | Amministratore Delegato | - | - |
Storia della carriera di Anna Steeger
Precedenti posizioni note di Anna Steeger
Società | Posizione | Inizio | Fine |
---|---|---|---|
ECKERT & ZIEGLER BEBIG | Direttore/Membro del Consiglio | - | - |
Independent Dir/Board Member | - | - |
Statistiche
Distribuzione geografica
Germania | 4 |
Belgio | 2 |
Posizioni
Chief Executive Officer | 2 |
Director/Board Member | 1 |
Independent Dir/Board Member | 1 |
Settori
Health Technology | 2 |
Finance | 2 |
Commercial Services | 2 |
Posizioni ricoperte
Attive
Inattive
Società quotate in Borsa
Aziende private
Società collegate
Aziende private | 4 |
---|---|
Eckert & Ziegler BEBIG SA
![]() Eckert & Ziegler BEBIG SA Pharmaceuticals: MajorHealth Technology Eckert & Ziegler BEBIG SA engages in the provision of medical devices. Its products include prostate seed brachytherapy, brain seed brachytherapy, high dose rate brachytherapy, ophthalmic brachytherapy and radiotherapy accessories. The company was founded on February 15, 1996, is headquartered in Seneffe, Belgium. | Health Technology |
1717 Life Sciences Ventures GmbH | Finance |
Polyventures GmbH | |
PentixaPharm GmbH
![]() PentixaPharm GmbH Miscellaneous Commercial ServicesCommercial Services Pentixapharm GmbH engages in the development, production, marketing, and distribution of medicines and radiopharmaceutical products, which act on the CXCR4 receptor. The company was founded on May 14, 2019 and is headquartered in Wuerzburg, Germany. | Commercial Services |
- Borsa valori
- Insiders
- Anna Steeger
- Esperienza